This is the authors' abstract. We don't add key points for this paper.
The innate immune system detects viral infections and mounts robust type I interferon (IFN-I) responses to establish antiviral defenses. However, the regulatory mechanisms that control the amplitude and duration of IFN-I signaling remain incompletely understood. Here, we identify microtubule affinity-regulating kinase 2 (MARK2)-a serine/threonine kinase of the AMPK family traditionally known for its roles in cell polarity and microtubule dynamics-as a regulator of antiviral immunity. MARK2 interacts with guanine nucleotide exchange factor H1 (GEF-H1) and phosphorylates it at Ser645 in a microtubule-dependent manner. Phosphorylated GEF-H1 then enhances TBK1 activation, thereby promoting strong induction of IFN-I and IFN-stimulated genes (ISGs). Furthermore, MARK2 drives transcriptional upregulation of GEF-H1 itself as an ISG, establishing a positive feedback loop that sustains antiviral signaling. Together, these findings identify MARK2 as an antiviral signaling kinase that amplifies innate immune responses through GEF-H1 phosphorylation, offering mechanistic insights into the regulation of innate antiviral immunity.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: